Keyphrases
Hepatitis E Virus
100%
Hepatitis E
62%
Hepatitis E Virus Infection
43%
Virus
36%
Blood Donors
33%
Wales
27%
Genotype 3
26%
Virus RNA
23%
Hepatitis E Virus Genotype
20%
Persistent Infection
19%
Risk Factors
18%
Epidemiology
17%
Donor Populations
17%
Autochthonous Hepatitis E
17%
Enzyme-linked Immunosorbent Assay (ELISA)
16%
Virus Detection
15%
Acute Hepatitis E
15%
Pork Products
14%
Blood Donation
14%
Deceased Donor
13%
Hepatitis E Infection
13%
Measles
13%
Solid Phase
13%
Retrospective Surveillance
13%
Prevalence Study
13%
COVID-19
13%
Mumps
13%
Chronic Infection
13%
Oral Fluid Testing
13%
Coronavirus Impact
13%
Immunization
13%
Blood Components
13%
Surveillance Studies
13%
South East England
13%
Viral Antigens
13%
Household Transmission
13%
Transmission Studies
13%
Wider Impacts
13%
IgM Antibody
13%
Chemiluminescent Enzyme Immunoassay (CLEIA)
13%
Nosocomial Transmission
13%
Universal Screening
13%
Viral Epidemiology
13%
Hepatitis A Virus
13%
United Kingdom
13%
Whole Genome Sequencing
13%
Extrahepatic Manifestations
13%
Hepatitis B Virus
13%
Hepatitis B Surface Antigen (HBsAg)
11%
Virus Transmission
10%
Medicine and Dentistry
Hepatitis E Virus
70%
Infection
43%
Virus
41%
Hepatitis E
29%
Blood Donor
25%
Virus Infection
21%
Enzyme Linked Immunosorbent Assay
16%
Blood Component
13%
COVID-19
13%
Virus Antigen
13%
Household
13%
Hepatitis A Virus
13%
Organ Donor
13%
Prevalence
13%
Virus RNA
9%
Immunoglobulin M
6%
Immunoglobulin G
6%
Virus Transmission
6%
Public Health
6%
Horizontal Disease Transmission
5%
Neurologic Disease
5%
Chronic Hepatitis
5%
Immunology and Microbiology
Hepatitis E Virus
55%
Virus
39%
Immunoassay
18%
Immunoglobulin M
17%
Prevalence
15%
Hepatitis E
15%
Measles
13%
Virus Antigen
13%
Virus Vaccine
13%
Blood Component
13%
Immunoglobulin M Antibody
13%
ELISA
13%
Hepatitis A Virus
13%
Chemoluminescence
13%
Whole Genome Sequencing
13%
Enzyme Immunoassay
13%
Hepatitis B Antigen
13%
HBsAg
13%
Hepatitis B Virus
13%
Viral Load
8%
Antigenicity
8%
Viral Disease
7%
Immunoglobulin G
6%
Immunocompromised Patient
6%
RNA Virus
6%
Blood Plasma
6%
Virus Transmission
5%